ELAVL1 promotes glycolysis in nasopharyngeal carcinoma cells by interacting with HMGB3 to stabilize HMGB3 mRNA, thereby activating β-catenin pathway. The gene discussed is ELAVL1; the disease is nasopharyngeal carcinoma.